These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 11374852

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.
    Boden WE.
    Am J Cardiol; 2000 Dec 21; 86(12A):19L-22L. PubMed ID: 11374850
    [Abstract] [Full Text] [Related]

  • 3. Rationale and design of the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol.
    Rubins HB, Robins SJ, Iwane MK, Boden WE, Elam MB, Fye CL, Gordon DJ, Schaefer EJ, Schectman G, Wittes JT.
    Am J Cardiol; 1993 Jan 01; 71(1):45-52. PubMed ID: 8420235
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial.
    Nyman JA, Martinson MS, Nelson D, Nugent S, Collins D, Wittes J, Fye CL, Wilt TJ, Robins SJ, Bloomfield Rubins H, VA-HIT Study Group.
    Arch Intern Med; 2002 Jan 28; 162(2):177-82. PubMed ID: 11802751
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF.
    Arterioscler Thromb Vasc Biol; 2008 Jun 28; 28(6):1172-8. PubMed ID: 18356553
    [Abstract] [Full Text] [Related]

  • 7. Are high-density lipoprotein and triglyceride levels important in secondary prevention: impressions from the BIP and VA-HIT trials.
    Rizos E, Mikhailidis DP.
    Int J Cardiol; 2002 Mar 28; 82(3):199-207; discussion 207-8. PubMed ID: 11911905
    [Abstract] [Full Text] [Related]

  • 8. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
    Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB, VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial.
    JAMA; 2001 Mar 28; 285(12):1585-91. PubMed ID: 11268266
    [Abstract] [Full Text] [Related]

  • 9. [Clinical study of the month. Usefulness of increasing HDL cholesterol in secondary prevention of coronary heart disease: results of the VA-HIT study].
    Scheen AJ.
    Rev Med Liege; 1999 Sep 28; 54(9):773-5. PubMed ID: 10589275
    [Abstract] [Full Text] [Related]

  • 10. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease.
    Bezafibrate Infarction Prevention (BIP) studyIsraeli Society for Prevention of Heart Attacks, Tel-Hashomer, Israel. behar@post.tau.ac.il.
    Circulation; 2000 Jul 04; 102(1):21-7. PubMed ID: 10880410
    [Abstract] [Full Text] [Related]

  • 11. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.
    Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227
    [Abstract] [Full Text] [Related]

  • 12. Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial.
    Robins SJ.
    Am J Cardiol; 2001 Dec 20; 88(12A):19N-23N. PubMed ID: 11788126
    [Abstract] [Full Text] [Related]

  • 13. Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention?
    Rizos E, Mikhailidis DP.
    Cardiovasc Res; 2001 Nov 20; 52(2):199-207. PubMed ID: 11684067
    [Abstract] [Full Text] [Related]

  • 14. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ.
    Circulation; 2006 Mar 28; 113(12):1556-63. PubMed ID: 16534013
    [Abstract] [Full Text] [Related]

  • 15. Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).
    Robins SJ, Rubins HB, Faas FH, Schaefer EJ, Elam MB, Anderson JW, Collins D, Veterans Affairs HDL Intervention Trial (VA-HIT).
    Diabetes Care; 2003 May 28; 26(5):1513-7. PubMed ID: 12716814
    [Abstract] [Full Text] [Related]

  • 16. Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial).
    Goldbourt U, Behar S, Reicher-Reiss H, Agmon J, Kaplinsky E, Graff E, Kishon Y, Caspi A, Weisbort J, Mandelzweig L.
    Am J Cardiol; 1993 Apr 15; 71(11):909-15. PubMed ID: 8465780
    [Abstract] [Full Text] [Related]

  • 17. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM.
    Am Heart J; 2002 Dec 15; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [Abstract] [Full Text] [Related]

  • 18. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW.
    Am J Cardiovasc Drugs; 2005 Dec 15; 5(6):379-87. PubMed ID: 16259526
    [Abstract] [Full Text] [Related]

  • 19. Evidence that triglycerides are an independent coronary heart disease risk factor.
    Cullen P.
    Am J Cardiol; 2000 Nov 01; 86(9):943-9. PubMed ID: 11053704
    [Abstract] [Full Text] [Related]

  • 20. [VA-HIT Study [Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study]].
    Noto H, Kinoshita M.
    Nihon Rinsho; 2001 Mar 01; 59 Suppl 3():442-7. PubMed ID: 11347111
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.